Keloid scars in type VI skin successfully treated with combined surgery and pulsed dye laser therapy

Eke, Ure; Díaz, Camilo; Abdullah, A.

doi:10.1111/bjd.12159

Cited by 5 publications

(5 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…While an early case report actually found PDL (585 nm) to result in keloid recurrence after previous flattening, subsequent studies have shown efficacy in keloid treatment [37]. A case series (n = 3) found post-shave-excision PDL treatment (595 nm) of keloids to result in no recurrence of lesions (0/3), and hypopigmentation was only seen in one patient [38]. A study of 26 patients with keloids who were treated with 595 nm PDL resulted in a significant decrease in VSS score, including improved pain and itch, pliability, and erythema [39].…”

Section: Pulse Dye Laser (Pdl)mentioning

confidence: 99%

A Review of Current Keloid Management: Mainstay Monotherapies and Emerging Approaches

Limmer

Glass

2020

Dermatol Ther (Heidelb)

View full text Add to dashboard Cite

Commonly affecting those with skin of color, keloids are an aberrant wound response that leads to wound tissue expanding above and beyond the original cutaneous injury. Keloids are notoriously and particularly difficult to treat because of their tendency to recur after excision. The current standard of care is intralesional steroid (triamcinolone acetonide). However, because no therapy has yet proven to be fully curative, keloid treatments have expanded to include a number of options, from injections to multimodal approaches. This review details current treatment of keloids with injections (bleomycin, verapamil, hyaluronic acid and hyaluronidase, botulinum toxin, and collagenase), cryotherapy, laser, radiofrequency ablation, radiation, extracorporeal shockwave therapy, pentoxifylline, and dupilumab.

show abstract

Section: Pulse Dye Laser (Pdl)mentioning

confidence: 99%

A Review of Current Keloid Management: Mainstay Monotherapies and Emerging Approaches

Limmer

Glass

2020

Dermatol Ther (Heidelb)

View full text Add to dashboard Cite

show abstract

“…12,13 The pigmentation changes in our study did not occur during the five-month follow-up period, whereas studies using other methods, such as pulse dye lasers, radiofrequency ablation, cryotherapy, and Bleomycin injections, reported hypo-, hyper-, or depigmentation in their patients. 12,[14][15][16][17][18] Based on the results of this survey, there was an improvement in the pliability of lesions. This improvement is comparable with results obtained from using CO 2 lasers and pulse dye lasers.…”

Section: Discussionmentioning

confidence: 86%

Keloid Treatment Using Plasma Exeresis: A Pilot Trial Study

et al. 2023

View full text Add to dashboard Cite

Introduction: Keloid scars and hypertrophic scars are more commonly seen after surgeries, suture placements, or other skin damages. Scars can be treated using a variety of methods, including topical compounds, surgery, and lasers. The aim of this study is to evaluate the effects of plasma exeresis on the treatment of keloid scars. Methods: This experimental study was conducted on patients with keloid scars, defined as a treatment-resistant subtype of scars with extension beyond the primary skin defect and cauliflower appearance, in different parts of the body. The patients were treated with 2-to-3-session plasma exeresis. Scars were examined based on the Vancouver scar scale (VSS) before and 5 months after the treatment. Results: A total number of 24 scars were enrolled in this study. The number of patients was 16. There was a decrease in the mean thickness of keloids from 2.20 to 0.54 (P=0.000). The mean pigmentation and pliability scores decreased from 1.54 and 2.16 to 0.375 and 0.541, respectively (P=0.001, 000). There was a significant reduction in the keloid scar vascularity score from 1.666 to 0.541 (P=0.000). There was a decrease from 0.708 to 0.00 (P=0.004) in the mean itchiness score. After the intervention, the mean pain score was 0.000, compared to 0.7500 before the intervention (P=0.003). There was a decrease in the total score from 8.958 to 2.000 (P=0.000). Conclusion: The plasma exeresis procedure is effective in destroying small keloid scars. Furthermore, results in less itching and pain, as well as no significant complications or recurrences.

show abstract

“…Results with other lasers like PDL, 980nm diode laser, Nd:YAG lasers, and Er:YAG laserswere also good in terms of pa ent sa sfac on and recurrence. [27][28][29][30]33,34 In these studies, combina on approach showed be er result than solo therapy. Laser treatments were mainly combined with surgical excision or ILCS.…”

Section: Discussionmentioning

confidence: 94%

“…Laser treatments were mainly combined with surgical excision or ILCS. 26,27,30,33 However, not all studies with laser showed exci ng results. 2 studies with CO2 laser and 1 study with PDLshowed complete recurrence of keloids.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Upcoming Therapeutic Modalities for the Treatment of Keloids: An Update

Keyal¹,

Bhatta²

2019

Nepal J Dermatol Venereol & Leprol

View full text Add to dashboard Cite

Introduction: Keloids are benign dermal tumors that generally form by local fibroblast proliferation and excessive collagen production following skin trauma. Several methods have been described for the treatment of keloid, often with suboptimal results and recurrences. Objective: To update literature that provides information regarding upcoming therapeutic modalities for the treatment of keloids, including lasers, radiofrequency (RF), photodynamic therapy (PDT), and ultraviolet A1 (UVA1) irradiation. Materials and Methods : A systematic review of the literature was performed for the original articles related to the treatment of keloids. The search terms ‘keloids’ and ‘lasers’ or ‘radiofrequency’ or ‘PDT’ or ‘UVA1’ was entered into a search of the National Library of Medicine’s PubMed Database. Result: The search returned a total of 188 sources, of which, 26 articles met our inclusion criteria. Conclusion: Combination approach is superior than solo therapy in the treatment of keloid. However, it is highly desirable that new emerging therapies undergo large-scale studies with long-term follow-up before being recommended conclusively as alternative therapies for the treatment of keloid. Moreover, lack of randomized clinical trials (RCTs) needs to be taken into consideration urgently.

show abstract

Keloid scars in type VI skin successfully treated with combined surgery and pulsed dye laser therapy

Cited by 5 publications

References 12 publications

A Review of Current Keloid Management: Mainstay Monotherapies and Emerging Approaches

A Review of Current Keloid Management: Mainstay Monotherapies and Emerging Approaches

Keloid Treatment Using Plasma Exeresis: A Pilot Trial Study

Upcoming Therapeutic Modalities for the Treatment of Keloids: An Update

Contact Info

Product

Resources

About